TWA
NKTR icon

TCI Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History

TCI Wealth Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-83
Closed -$2.82K – 2600
2022
Q4 		$2.82K Buy
83
+62
+295% +$3K ﹤0.01% 1887
2022
Q3 		$1K Sell
21
-13
-38% -$773 ﹤0.01% 2124
2022
Q2 		$2K Buy
+34
New +$2.15K ﹤0.01% 2018
2022
Q1 		– Sell
-39
Closed -$8K – 2377
2021
Q4 		$8K Buy
39
+37
+1,850% +$8.03K ﹤0.01% 1343
2021
Q3 		$0 Sell
2
-11
-85% -$2.65K ﹤0.01% 2510
2021
Q2 		$3K Buy
13
+11
+550% +$3.04K ﹤0.01% 1807
2021
Q1 		$1K Hold
2
– – ﹤0.01% 2088
2020
Q4 		$0 Sell
2
-18
-90% -$4.65K ﹤0.01% 1613
2020
Q3 		$5K Hold
20
– – ﹤0.01% 779
2020
Q2 		$7K Buy
20
+9
+82% +$2.81K ﹤0.01% 663
2020
Q1 		$3K Sell
11
-4
-27% -$1.24K ﹤0.01% 901
2019
Q4 		$5K Hold
15
– – ﹤0.01% 860
2019
Q3 		$4K Sell
15
-3
-17% -$1.1K ﹤0.01% 877
2019
Q2 		$10K Buy
18
+2
+13% +$1K ﹤0.01% 627
2019
Q1 		$8K Buy
16
+1
+7% +$593 ﹤0.01% 678
2018
Q4 		$8K Buy
15
+1
+7% +$604 ﹤0.01% 673
2018
Q3 		$13K Buy
14
+1
+8% +$854 0.01% 588
2018
Q2 		$9K Hold
13
– – ﹤0.01% 655
2018
Q1 		$20K Hold
13
– – 0.01% 486
2017
Q4 		$11K Hold
13
– – ﹤0.01% 611
2017
Q3 		$5K Hold
13
– – ﹤0.01% 737
2017
Q2 		$4K Hold
13
– – ﹤0.01% 816
2017
Q1 		$5K Hold
13
– – ﹤0.01% 715
2016
Q4 		$2K Buy
+13
New +$2.64K ﹤0.01% 1030

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCI Wealth Advisors's NKTR Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 83 shares — an estimated $2.82K sold.

TCI Wealth Advisors first reported a position in NKTR in Q4 2016 and held it in 24 quarters. The position peaked at $20K in Q1 2018. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 83 Nektar Therapeutics shares in Q1 2023, an estimated $2.82K.
  • TCI Wealth Advisors first reported a position in Nektar Therapeutics in Q4 2016 and held it in 24 quarters.
  • TCI Wealth Advisors's Nektar Therapeutics position peaked at $20K in Q1 2018.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.